Stockreport

Genmab acquires biotechnology company ProfoundBio in $1.8bn deal [Yahoo! Finance]

Genmab A/S - American Depositary Shares  (GMAB) 
PDF ProfoundBio specialises in the development of antibody-drug conjugates (ADCs) and technologies for cancer treatment. The latest development comes after the companies [Read more]